Log in

NASDAQ:FENCFennec Pharmaceuticals Stock Price, Forecast & News

$8.27
+0.08 (+0.98 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$8.06
Now: $8.27
$8.40
50-Day Range
$7.25
MA: $8.21
$9.39
52-Week Range
$3.75
Now: $8.27
$9.75
Volume128,600 shs
Average Volume394,124 shs
Market Capitalization$209.73 million
P/E RatioN/A
Dividend YieldN/A
Beta0.25
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.
Read More
Fennec Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.00 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FENC
CUSIPN/A
Phone919-636-4530

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.60 per share

Profitability

Net Income$-12,770,000.00

Miscellaneous

EmployeesN/A
Market Cap$209.73 million
Next Earnings Date8/14/2020 (Estimated)
OptionableOptionable

Receive FENC News and Ratings via Email

Sign-up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter.

Fennec Pharmaceuticals (NASDAQ:FENC) Frequently Asked Questions

How has Fennec Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Fennec Pharmaceuticals' stock was trading at $6.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FENC shares have increased by 24.7% and is now trading at $8.27. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Fennec Pharmaceuticals?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fennec Pharmaceuticals in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Fennec Pharmaceuticals.

When is Fennec Pharmaceuticals' next earnings date?

Fennec Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020. View our earnings forecast for Fennec Pharmaceuticals.

How were Fennec Pharmaceuticals' earnings last quarter?

Fennec Pharmaceuticals Inc (NASDAQ:FENC) announced its quarterly earnings results on Thursday, May, 14th. The company reported ($0.19) earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of ($0.19). View Fennec Pharmaceuticals' earnings history.

What price target have analysts set for FENC?

3 brokers have issued 12-month target prices for Fennec Pharmaceuticals' shares. Their forecasts range from $15.00 to $18.00. On average, they anticipate Fennec Pharmaceuticals' share price to reach $17.00 in the next twelve months. This suggests a possible upside of 105.6% from the stock's current price. View analysts' price targets for Fennec Pharmaceuticals.

Has Fennec Pharmaceuticals been receiving favorable news coverage?

Headlines about FENC stock have been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Fennec Pharmaceuticals earned a daily sentiment score of 1.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Fennec Pharmaceuticals.

Are investors shorting Fennec Pharmaceuticals?

Fennec Pharmaceuticals saw a drop in short interest in June. As of June 30th, there was short interest totaling 514,400 shares, a drop of 6.2% from the June 15th total of 548,400 shares. Based on an average daily trading volume, of 150,500 shares, the short-interest ratio is presently 3.4 days. Approximately 2.4% of the company's stock are sold short. View Fennec Pharmaceuticals' Current Options Chain.

Who are some of Fennec Pharmaceuticals' key competitors?

What other stocks do shareholders of Fennec Pharmaceuticals own?

Who are Fennec Pharmaceuticals' key executives?

Fennec Pharmaceuticals' management team includes the following people:
  • Mr. Rostislav Raykov, Pres, CEO & Director (Age 42)
  • Mr. Robert C. Andrade, Chief Financial Officer (Age 43)
  • Mr. Mark Gowland, Controller
  • Mr. Lei Fang, Pres of Pharstat Inc
  • Ms. Anne McKay, Regulatory Consultant (Age 64)

What is Fennec Pharmaceuticals' stock symbol?

Fennec Pharmaceuticals trades on the NASDAQ under the ticker symbol "FENC."

How do I buy shares of Fennec Pharmaceuticals?

Shares of FENC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fennec Pharmaceuticals' stock price today?

One share of FENC stock can currently be purchased for approximately $8.27.

How big of a company is Fennec Pharmaceuticals?

Fennec Pharmaceuticals has a market capitalization of $209.73 million. The company earns $-12,770,000.00 in net income (profit) each year or ($0.64) on an earnings per share basis.

What is Fennec Pharmaceuticals' official website?

The official website for Fennec Pharmaceuticals is www.fennecpharma.com.

How can I contact Fennec Pharmaceuticals?

Fennec Pharmaceuticals' mailing address is PO BOX 13628 68 TW ALEXANDER DRIVE, DURHAM NC, 27709. The company can be reached via phone at 919-636-4530.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.